# GenoMed4ALL: Improving SCD Classification and Prognosis by AI

> **NCT06019208** · — · UNKNOWN · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 1000 (estimated)

## Conditions studied

- Sickle Cell Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06019208
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06019208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06019208, "GenoMed4ALL: Improving SCD Classification and Prognosis by AI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06019208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*